09 November 2021: Clinical Research
Association Between Severe Chronic Obstructive Pulmonary Disease and Polyneuropathy
Ahmet Arisoy 1ABCDEF* , Abdullah Yilgor 2BCD , İbrahim H. Uney 1BCDOI: 10.12659/MSM.932690
Med Sci Monit 2021; 27:e932690
Table 3 Latency, amplitude, and velocity values of the motor component of the nerves.
| COPD group | Control group | p-value | |
|---|---|---|---|
| Latency | 7.49±0.55 | 7.39±0.65 | .66 |
| Amplitude | 6.54±2.49 | 6.00±1.47 | .542 |
| Velocity | 54.39±3.60 | 57.35±4.51 | .047 |
| Latency | 6.57±1.08 | 6.77±0.87 | .624 |
| Amplitude | 6.77±2.33 | 6.07±1.63 | .408 |
| Velocity | 57.16±6.58 | 59.07±5.39 | .433 |
| Latency | 10.94±3.17 | 11.93±1.04 | .365 |
| Amplitude | 1.80±1.43 | 1.73±0.75 | .894 |
| Velocity | 39.73±11.16 | 46.04±4.81 | .109 |
| Latency | 14.25±3.07 | 15.03±3.27 | .508 |
| Amplitude | 3.73±2.03 | 3.41±1.70 | .665 |
| Velocity | 40.35±8.40 | 40.36±6.15 | .990 |